Sign in

You're signed outSign in or to get full access.

Claritev (CTEV)

Earnings summaries and quarterly performance for Claritev.

Recent press releases and 8-K filings for CTEV.

Claritev Management Discusses Customer Renewals, Growth Strategy, and Market Outlook
CTEV
Revenue Acceleration/Inflection
New Projects/Investments
Guidance Update
  • Claritev recently renewed its top 10 customers, which comprise 70% of its revenue, and has seen a 67% increase in its pipeline over the last year, with half of that growth coming from existing clients.
  • The company's primary revenue model, PSAV (Payment Savings as Value), generates 88% of its revenue and is an ROI-based model where Claritev earns a percentage of the savings it identifies for customers.
  • Claritev's growth is driven by rising healthcare inflation and increased demand for transparency, with out-of-network spend expected to remain stable at 5%-7% of overall healthcare spend, particularly in high-ticket categories like ambulatory surgery, musculoskeletal, and behavioral health.
  • The No Surprises Act (NSA), initially perceived as a challenge, has become a growth opportunity for Claritev, evolving into its third-largest product category within its analytics business by supporting clients through the IDR process.
  • Claritev has booked $45 million in new ACV year-to-date through Q3 and anticipates closing an additional $15 million by year-end, driven by an expanded sales force and increased focus on multiple vertical markets.
Dec 4, 2025, 1:00 PM
Claritev (CTEV) Discusses Strong Customer Renewals, Pipeline Growth, and Revenue Acceleration
CTEV
Revenue Acceleration/Inflection
New Projects/Investments
  • Claritev (CTEV) recently renewed its top 10 customers, which comprise 70% of its revenue, providing a strong foundation for future growth.
  • The company reported a 67% increase in its pipeline over the last year, with half of this growth coming from existing clients.
  • Commercial health plan medical charges processed grew 7% year over year in 2024 and 8.5% year to date in 2025, driven by healthcare inflation and a higher mix of high-ticket out-of-network claims.
  • Claritev's core PSAV model, generating 88% of revenue, is an ROI-based model where the company earns a percentage of savings it identifies for clients in out-of-network claims.
  • The company booked $45 million in new Annual Contract Value (ACV) year to date through Q3 and expects an additional $15 million by year-end.
Dec 4, 2025, 1:00 PM
Claritev Corporation CFO Discusses 2025 Turnaround and Growth Strategy
CTEV
Revenue Acceleration/Inflection
New Projects/Investments
Guidance Update
  • Claritev Corporation's CFO, Doug Gareiss, stated that 2025 was a successful turning point for the company, transitioning from foundational efforts in 2024 to focusing on sustainable growth.
  • The company has expanded into six new market segments, including the provider market (with international reach), government, and employer space, utilizing new solutions like BenInsights and Advanced Code Editing.
  • Claritev anticipates booking at least $60 million in Annual Contract Value (ACV) for the year, having already secured 491 deals year-to-date at an average of approximately $80,000-$90,000.
  • A strategic partnership with Oracle, initially for technology infrastructure, has evolved into a go-to-market collaboration, with 3,000 Oracle Cloud reps now selling Claritev's BenInsights solution and enabling rapid international deployment.
Dec 2, 2025, 12:30 PM
Claritev CFO Discusses 2025 Turnaround and Growth Strategy
CTEV
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
  • Claritev's CFO, Doug Gareiss, stated that 2025 is a "turn" year focused on sustainable growth, following a foundational 2024.
  • The company has expanded into six new market segments, including provider, government, and employer spaces, leveraging its technology assets; notably, its Advanced Code Editing product reduced denial rates by 50% for Burjeel Holdings, generating $40 million in economic value.
  • A strategic partnership with Oracle has enabled rapid product deployment and integrated Claritev's BenInsights solution into Oracle's sales channels, with 3,000 Oracle Cloud reps now enabled to sell the solution.
  • Claritev expects to book at least $60 million in Annual Contract Value (ACV) for 2025, supported by a $200 million pipeline, signaling future revenue growth.
  • The core business was stabilized through financial accountability, efficiency improvements (growing with 3% less headcount), and strengthened client relationships, with the entire business now viewed as a growth business.
Dec 2, 2025, 12:30 PM
Claritev Corporation Outlines 2025 Turnaround and Future Growth
CTEV
Revenue Acceleration/Inflection
New Projects/Investments
Guidance Update
  • Claritev Corporation successfully completed its "turn" in 2025 and is now focused on sustainable growth, having opened six new market segments including provider, government, and employer spaces.
  • The company's international expansion, particularly in the Middle East, has demonstrated significant value, with its Advanced Code Editing product reducing a major provider's denial rate by 50%, generating $40 million in economic value for Burjeel Holdings.
  • A strategic partnership with Oracle has facilitated a rapid digital transformation, deploying applications to Oracle Cloud Infrastructure in nine months, and established a new go-to-market channel with 3,000 Oracle Cloud reps selling Claritev's BenInsights solution.
  • Claritev expects to book at least $60 million in Annual Contract Value (ACV) for 2025, with a current pipeline of approximately $200 million, indicating future revenue acceleration, with a good portion expected to turn into revenue in 2026.
Dec 2, 2025, 12:30 PM
Claritev Reports Strong Q3 2025 Results and Raises Full-Year Guidance
CTEV
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Claritev Corporation announced that "the turn has happened," reporting a second consecutive beat-and-raise quarter with Q3 2025 total revenue of $246 million, up 6.7% year-over-year, and Adjusted EBITDA of $155.1 million, a 9.5% increase.
  • The company raised its full-year revenue guidance to approximately 2.8%-3.2% growth versus the prior year and narrowed its Adjusted EBITDA margin guidance to 62.5%-63%.
  • Strategic successes include renewing all top 10 clients for extended terms, adding 20 new logos year-to-date, and closing $15 million in annual contract value (ACV) in Q3, contributing to a 67% increase in pipeline year-to-date.
  • Claritev expects to book approximately $60 million of incremental ACV this year, largely anticipated to convert to revenue in 2026 and beyond, with a non-recurring revenue benefit of $15 million-$18 million expected for the full year 2025.
Nov 7, 2025, 1:00 PM
Claritev Corporation Reports Strong Q3 2025 Results and Raises Full-Year Guidance
CTEV
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Claritev Corporation (CTEV) reported Q3 2025 total revenue of $246 million, an increase of 6.7% year over year, and Adjusted EBITDA of $155.1 million, up 9.5% year over year.
  • The company raised its full-year revenue guidance to approximately 2.8%-3.2% growth versus the prior year and tightened its Adjusted EBITDA margin guidance to 62.5%-63%.
  • Claritev successfully renewed its top 10 clients for extended terms, added 20 new logos year-to-date, and saw its pipeline grow 67% year to date.
  • The company closed $15 million in annual contract value (ACV) in Q3 2025 and expects to book approximately $60 million of incremental ACV for the full year, with 60%-65% anticipated to convert to revenue in 2026.
  • Claritev is expanding into new market verticals, including international markets, and made significant investments in technology, data, and AI.
Nov 7, 2025, 1:00 PM
CTEV Announces Strong Q3 2025 Results and Raises Full-Year Guidance
CTEV
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • CTEV reported Q3 2025 revenue of $246.0 million, representing a 6.7% increase compared to Q3 2024, and achieved Adjusted EBITDA of $155.1 million with an Adjusted EBITDA margin of 63.1%, which is 162 basis points higher than the prior year.
  • This performance marks the second consecutive quarter of topline and profitability growth, leading the company to raise its full-year guidance.
  • In Q3 2025, the company closed approximately $15 million in annual contract value (ACV) bookings, saw a 26% increase in Average ACV, and renewed all Top Ten clients.
  • Unlevered Free Cash Flow for Q3 2025 was $113.2 million.
Nov 7, 2025, 1:00 PM
Claritev Corporation Reports Strong Q3 2025 Results and Raises Full-Year Guidance
CTEV
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Claritev Corporation reported strong Q3 2025 financial results, with total revenue of $246 million, an increase of 6.7% year-over-year, and adjusted EBITDA of $155.1 million, up 9.5% year-over-year.
  • The company raised its full-year 2025 revenue guidance to approximately 2.8% to 3.2% growth versus prior year and tightened its adjusted EBITDA margin guidance to 62.5% to 63%.
  • CTEV successfully renewed its top 10 clients for extended terms, including a previously discussed single client, providing stability and visibility for future growth.
  • Management stated that the "turn has happened," with Q3 2025 marking the second consecutive beat and raised quarter, driven by its core business.
  • The company achieved significant growth in new business, adding five new logos in Q3 2025 and closing $15 million in annual contract value (ACV) for the quarter, with year-to-date pipeline growth of 67%.
Nov 7, 2025, 1:00 PM
Claritev Corporation Reports Q3 2025 Results and Updates Guidance
CTEV
Earnings
Guidance Update
Revenue Acceleration/Inflection
  • Claritev Corporation reported Q3 2025 revenues of $246.0 million, an increase of 6.7% compared to Q3 2024.
  • The company's net loss for Q3 2025 was $69.8 million, a substantial improvement from the $391.5 million net loss in Q3 2024.
  • Adjusted EBITDA increased by 9.5% to $155.1 million in Q3 2025, with an Adjusted EBITDA Margin of 63.1%.
  • Free Cash Flow for Q3 2025 was $(16.3) million, compared to $41.1 million in Q3 2024.
  • Claritev raised its full-year 2025 revenue guidance to 2.8% to 3.2% growth from FY 2024 (previously Flat to 2%) and updated its Adjusted EBITDA Margin guidance to 62.5% to 63.0%.
Nov 7, 2025, 11:00 AM